1 November 2022: Aker BioMarine ASA ("Aker BioMarine" or "the company") reports
revenues of USD 68 million and Adjusted EBITDA of USD 19 million for the third
quarter 2022. 

"Aker BioMarine delivers higher sales growth and EBITDA, driven by improvement
in all segments compared to the same quarter last year. Especially the Qrill
segment reports strong figures, with high sales volumes and prices for Qrill
Aqua. We have significantly improved our Antarctic krill harvesting, and so far
this year, the production of krill meal is above 50,000 tons, which is 23% above
last year.", said Matts Johansen, CEO of Aker BioMarine.

Highlights third quarter:
- Revenues of USD 68 million, up 10% from same quarter last year
- Adjusted EBITDA of USD 19 million, up from USD 15 million the same quarter
last year
- Sales in the Ingredients segment, up 11% from same quarter last year
- Sales in the Brands segment, up 10% from same quarter last year
- Offshore production volume was 12,737 MT in the quarter, 77% above same
quarter last year

For 2022, Aker BioMarine targets revenue growth of 8%-12%, with an adj. EBITDA
margin of 23-26%. The company expects a lower revenue growth and at the same
time higher margins than previously targeted, which implies an unchanged
targeted adj. EBITDA. 


At 09:00 CET today, the management hosts a webcast. Following the presentation,
there will be a Q&A session, where written questions can be submitted to
ir@akerbiomarine.com.

The webcasted presentation will be in English. To join, please use the link that
is available at www.akerbiomarine.com/investor. 

A replay of the presentation and Q&A session material will be made available
soon after the presentation at the same web address.

For further information, please contact 
Carl Christian Bachke, Investor Relations
Mobile: +47 909 808 48
Email: carl.bachke@akerbiomarine.com  

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.